Free Trial

Voyager Therapeutics (VYGR) Competitors

Voyager Therapeutics logo
$3.28 -0.01 (-0.15%)
As of 11:53 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

VYGR vs. AMLX, AVBP, IMTX, IMNM, NUVB, MGTX, GYRE, AUTL, PHAR, and DAWN

Should you be buying Voyager Therapeutics stock or one of its competitors? The main competitors of Voyager Therapeutics include Amylyx Pharmaceuticals (AMLX), ArriVent BioPharma (AVBP), Immatics (IMTX), Immunome (IMNM), Nuvation Bio (NUVB), MeiraGTx (MGTX), Gyre Therapeutics (GYRE), Autolus Therapeutics (AUTL), Pharming Group (PHAR), and Day One Biopharmaceuticals (DAWN). These companies are all part of the "pharmaceutical products" industry.

Voyager Therapeutics vs. Its Competitors

Amylyx Pharmaceuticals (NASDAQ:AMLX) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, media sentiment, valuation and dividends.

Amylyx Pharmaceuticals has a beta of -0.49, indicating that its stock price is 149% less volatile than the S&P 500. Comparatively, Voyager Therapeutics has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500.

Amylyx Pharmaceuticals has a net margin of 0.00% compared to Voyager Therapeutics' net margin of -126.49%. Voyager Therapeutics' return on equity of -27.36% beat Amylyx Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Amylyx PharmaceuticalsN/A -77.21% -63.84%
Voyager Therapeutics -126.49%-27.36%-21.06%

In the previous week, Amylyx Pharmaceuticals and Amylyx Pharmaceuticals both had 4 articles in the media. Amylyx Pharmaceuticals' average media sentiment score of 0.72 beat Voyager Therapeutics' score of -0.21 indicating that Amylyx Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Amylyx Pharmaceuticals
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Voyager Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

95.8% of Amylyx Pharmaceuticals shares are owned by institutional investors. Comparatively, 48.0% of Voyager Therapeutics shares are owned by institutional investors. 11.7% of Amylyx Pharmaceuticals shares are owned by insiders. Comparatively, 6.4% of Voyager Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Amylyx Pharmaceuticals presently has a consensus target price of $11.75, indicating a potential upside of 42.94%. Voyager Therapeutics has a consensus target price of $13.39, indicating a potential upside of 308.85%. Given Voyager Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Voyager Therapeutics is more favorable than Amylyx Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Amylyx Pharmaceuticals
0 Sell rating(s)
2 Hold rating(s)
9 Buy rating(s)
2 Strong Buy rating(s)
3.00
Voyager Therapeutics
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13

Voyager Therapeutics has lower revenue, but higher earnings than Amylyx Pharmaceuticals. Amylyx Pharmaceuticals is trading at a lower price-to-earnings ratio than Voyager Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amylyx Pharmaceuticals$87.37M8.39-$301.74M-$3.11-2.64
Voyager Therapeutics$80M2.27-$65M-$1.46-2.24

Summary

Amylyx Pharmaceuticals and Voyager Therapeutics tied by winning 8 of the 16 factors compared between the two stocks.

Get Voyager Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VYGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VYGR vs. The Competition

MetricVoyager TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$181.46M$3.07B$5.69B$9.49B
Dividend YieldN/A2.44%4.05%3.99%
P/E Ratio-2.2521.0428.0020.03
Price / Sales2.27251.99397.6083.98
Price / CashN/A41.9636.1958.45
Price / Book0.608.268.655.83
Net Income-$65M-$55.19M$3.24B$258.39M
7 Day Performance1.71%5.52%3.62%2.50%
1 Month Performance9.17%18.20%11.16%12.85%
1 Year Performance-63.20%7.33%35.16%21.38%

Voyager Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VYGR
Voyager Therapeutics
3.8799 of 5 stars
$3.28
-0.2%
$13.39
+308.9%
-63.0%$181.46M$80M-2.25100
AMLX
Amylyx Pharmaceuticals
3.1821 of 5 stars
$8.41
+9.5%
$11.75
+39.7%
+328.1%$749.68M-$1.27M-2.70200High Trading Volume
AVBP
ArriVent BioPharma
2.2633 of 5 stars
$21.87
+1.1%
$39.29
+79.6%
+7.1%$748.24MN/A-5.8040Positive News
Analyst Forecast
Analyst Revision
IMTX
Immatics
3.0324 of 5 stars
$6.11
+2.3%
$14.67
+140.0%
-50.1%$742.67M$168.65M-35.94260News Coverage
IMNM
Immunome
1.8566 of 5 stars
$8.51
-1.5%
$23.33
+174.2%
-22.7%$740.46M$9.04M-2.6840
NUVB
Nuvation Bio
1.9489 of 5 stars
$2.15
-2.1%
$7.17
+232.7%
-22.1%$732.92M$7.87M-0.9260
MGTX
MeiraGTx
4.2639 of 5 stars
$8.89
+5.0%
$24.00
+170.0%
+78.0%$714.40M$33.28M-3.83300News Coverage
Insider Trade
GYRE
Gyre Therapeutics
N/A$7.61
+1.6%
N/A-50.3%$713.51M$105.76M380.6940
AUTL
Autolus Therapeutics
2.6982 of 5 stars
$2.65
+7.3%
$9.32
+251.7%
-37.5%$705.27M$10.12M-3.01330Positive News
Analyst Forecast
PHAR
Pharming Group
2.4075 of 5 stars
$10.35
+3.5%
$30.00
+189.9%
+15.2%$704.12M$320.71M-51.75280Positive News
Upcoming Earnings
DAWN
Day One Biopharmaceuticals
2.7714 of 5 stars
$6.93
+2.1%
$29.00
+318.5%
-56.4%$702.44M$161.92M-9.7660Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:VYGR) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners